Modified Polio Vaccine Extends Lives in U.S. Brain Cancer Study Modified Polio Vaccine Extends Lives in U.S. Brain Cancer Study
Some 21% of patients with advanced brain cancer treated with a modified polio vaccine were alive after three years, compared with 4% of patients with similar tumors who received standard therapies, U.S. researchers said on Tuesday.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer Vaccines | Health | Neurology | Polio | Polio Vaccine | Study | Vaccines